neuropathies. Pract Neurol. 2015 Jun;15(3):187-98.
Abstract
Most general neurologists will come across CMT and related disorders in their daily practice. A positive family history and slowly progressive disease course are the strongest clues to a genetic aetiology.
Genetic testing in CMT has been transformed by the introduction of next-generation sequencing. CMT1A due to the 17p duplication remains the commonest type of CMT and should be tested first in any patient with sporadic or autosomal dominant CMT1 before proceeding to panel or whole exome testing.
The new challenge in CMT and related disorders is in determining the true pathogenic mutation among a handful of novel variants identified in several known disease genes. This can be time consuming and requires a detailed clinical assessment to define the phenotype and where possible the evaluation of affected and unaffected family members.
Although there are no treatments for CMT and related disorders, there is much that can be done to improve a patient's quality of life. Physiotherapists, orthotists and podiatrists can offer advice on orthotics and stretching exercises to prevent Achilles tendon contractures; where there is progressive foot deformity or pain, an orthopaedic foot surgeon with experience in CMT may be consulted.
Courtesy of http://www.medscape.com/viewarticle/845089?nlid=87825_3001&src=wnl_edit_medp_neur&uac=60196BR&spon=26&impID=811708&faf=1
No comments:
Post a Comment